Singapore markets closed

Straits Times Index
3,313.48
+8.49(+0.26%)
Nikkei
38,787.38
-132.88(-0.34%)
Hang Seng
19,553.61
+177.08(+0.91%)
FTSE 100
8,420.26
-18.39(-0.22%)
Bitcoin USD
66,860.01
+1,512.91(+2.32%)
CMC Crypto 200
1,350.62
-23.22(-1.69%)

Pacific Biosciences of California, Inc. (PACB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

2.0200

-0.1700

(-7.76%)

At close: 04:00PM EDT

2.0300

+0.01

(+0.50%)

After hours:

05:28PM EDT

Trade prices are not sourced from all markets

Press releases

PR Newswire
Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases
Ambry Genetics, a prominent leader in clinical genomic testing and a subsidiary of REALM IDx, Inc., along with PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced their companies' selection by the University of California, Irvine (UCI) and the GREGoR Consortium (Genomics Research to Elucidate the Genetics of Rare diseases) to support the Pediatric Mendelian Genomics Research Center (MGRC) program to better understand the underlying bi
PR Newswire
PacBio Announces First Quarter 2024 Financial Results
PacBio (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2024.
PR Newswire
PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance
Announces Plan to Reduce Annualized Operating Expense Run Rate by $50 - $75 Million